For media inquiries, please contact:
Stephanie Dunn, Manager, Research Communications | 604-875-2401

Click on a tag to sort the news stories by theme:

  • Fewer injections effectively prevent a dangerous virus in at-risk infants

    January 04, 2016
    Researchers have found three to four doses of the preventative drug palivizumab protect at-risk infants from a serious respiratory virus as effectively as five doses. The Canadian Pediatric Society recently revised their national guidelines for the administration of palivizumab in response to the collaborative research conducted at CFRI and BC Children’s Hospital.
    Full story